# RPG Life Sciences (NSE: RPGLIFE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/RPGLIFE · Pivot · prices to 22 Oct 2026

RPG Life Sciences (NSE: RPGLIFE) closed at ₹2,754.80 on 22 Oct 2026, down 2.31% on the day. With a market capitalisation of ₹4,556 Cr, it ranks 816th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 39.6× trailing earnings, against a return on equity of 11.5% in FY07. Over the past year the share price has risen 18.9%. Its 52-week range is ₹1,733.00 (23 Mar 2026) to ₹3,127.80 (25 Sep 2026); the last close is 11.9% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹196 Cr (+15.8% year on year) and net profit ₹31 Cr (+17.0%), on a consolidated basis. Promoters held 72.95% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹2,754.80 |
| Market cap | ₹4,556 Cr |
| P/E (trailing) | 39.6 |
| ROE | 11.5% (FY07) |
| ROCE | 5.1% (FY07) |
| Debt to equity | 1.19 |
| 52-week high | ₹3,127.80 (25 Sep 2026) |
| 52-week low | ₹1,733.00 (23 Mar 2026) |
| 1-year return | +18.9% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹196 Cr | +15.8% | ₹31 Cr | +17.0% | ₹18.60 |
| Q4 FY26 | ₹177 Cr | +23.6% | ₹30 Cr | −74.5% | ₹18.08 |
| Q3 FY26 | ₹180 Cr | +4.2% | ₹22 Cr | −36.6% | ₹13.38 |
| Q2 FY26 | ₹182 Cr | — | ₹37 Cr | — | ₹22.28 |
| Q1 FY26 | ₹169 Cr | — | ₹26 Cr | — | ₹15.90 |
| Q4 FY25 | ₹143 Cr | — | ₹117 Cr | — | ₹70.96 |
| Q3 FY25 | ₹173 Cr | — | ₹35 Cr | — | ₹21.12 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY07 | ₹120 Cr | ₹8 Cr |
| FY06 | ₹144 Cr | ₹26 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 72.95%
- Foreign institutions: 0.95%
- Domestic institutions: 8.67%
- Non-institutions: 17.42%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [IOL Chemicals and Pharmaceuticals](https://app.pivotnow.in/stock/IOLCP) | ₹173.27 | ₹5,086 Cr | 36.9 | — |
| [Zota Health Care](https://app.pivotnow.in/stock/ZOTA) | ₹1,304.00 | ₹4,516 Cr | — | — |
| [Jeena Sikho Lifecare](https://app.pivotnow.in/stock/JSLL) | ₹360.05 | ₹4,475 Cr | 20.3 | — |
| [Novartis India](https://app.pivotnow.in/stock/NOVARTIND) | ₹1,810.70 | ₹4,471 Cr | 48 | — |
| [Orchid Pharma](https://app.pivotnow.in/stock/ORCHPHARMA) | ₹876.25 | ₹4,444 Cr | 214.2 | — |
| [SMS Pharmaceuticals](https://app.pivotnow.in/stock/SMSPHARMA) | ₹434.55 | ₹4,070 Cr | 39 | — |

## Questions and answers

### What is the share price of RPG Life Sciences today?

RPG Life Sciences (NSE: RPGLIFE) last closed at ₹2,754.80 on 22 Oct 2026. Its 52-week high is ₹3,127.80 and its 52-week low is ₹1,733.00.

### What is the market cap of RPG Life Sciences?

RPG Life Sciences' market capitalisation is ₹4,556 Cr (₹4,556 Cr) at the 22 Oct 2026 close, ranking 816th among the NSE companies Pivot tracks.

### What is the P/E ratio of RPG Life Sciences?

RPG Life Sciences trades at a trailing P/E of 39.6. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 39.

### What is the ROE and ROCE of RPG Life Sciences?

Return on equity was 11.5% in FY07 and return on capital employed was 5.1% in FY07 (consolidated figures).

### Is RPG Life Sciences a debt-free company?

No. RPG Life Sciences' debt-to-equity ratio was 1.19 in FY07, with total debt of ₹85 Cr.

### What were RPG Life Sciences' latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), RPG Life Sciences reported revenue of ₹196 Cr, +15.8% year on year, and net profit of ₹31 Cr, +17.0% year on year.

### How has RPG Life Sciences stock performed over the last year?

RPG Life Sciences' share price has risen 18.9% over the past year, −7.7% over three months and −0.3% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of RPG Life Sciences?

As of 30 Jun 2026: promoters 72.95%, foreign institutions 0.95%, domestic institutions 8.67%, non-institutions 17.42%.

### Who are RPG Life Sciences' competitors?

The listed Pharma & Healthcare companies closest to RPG Life Sciences by market cap are IOL Chemicals and Pharmaceuticals, Zota Health Care, Jeena Sikho Lifecare, Novartis India, Orchid Pharma and SMS Pharmaceuticals.

### Is RPG Life Sciences a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out RPG Life Sciences' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on RPGLIFE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.